Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050984893> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2050984893 endingPage "487" @default.
- W2050984893 startingPage "480" @default.
- W2050984893 abstract "<h3>Background and Objectives</h3> Intrathecal (IT) administration of bupivacaine (BUP) for treatment of “refractory” pain has sometimes been associated with unacceptable side effects. This study was undertaken to determine if IT-ropivacaine (ROP) can reduce the rate and intensity of these side effects e.g., urinary retention, paresthesia, and particularly, paresis with gait impairment. A prospective, crossover, double-blind, randomized study. <h3>Methods</h3> Twenty-one patients were enrolled, 9 dropped out of the study, and data were analyzed from 12 patients. Patients were treated by insertion of IT tunneled nylon catheters, continuous infusion of 0.5% ROP followed by 0.5% BUP or 0.5% BUP followed by 0.5% ROP solutions from an external electronic pump. Each local anesthetic was infused for 7 days, and their order of infusion randomized. The comparative efficacy of the ROP and BUP IT infusions was assessed from the daily doses of IT ROP and IT BUP, oral and parenteral opioids, and daily scores of nonopioid analgetic and sedative drug consumption. Self-reported pain intensity (visual analogue scale [VAS] mean scores) and scores of Bromage relaxation, ambulation, nocturnal sleep pattern, rates of side-effects attributable to the IT drugs, the patients9 assessment of the IT ROP <i>v</i> the IT BUP periods of the trial, and the comparative daily cost of IT ROP <i>v</i> IT BUP were recorded. <h3>Results</h3> The daily doses of the local anesthetics used were 23% higher for ROP than for BUP. Further, the daily cost was ≈3 times higher for ROP than for BUP. No other significant differences between IT ROP and IT BUP were found. <h3>Conclusion</h3> The results of this study do not support the hypothesis that IT infusion of 0.5% ROP has advantages over IT infusion of 0.5% BUP when administered for relief of “refractory” pain." @default.
- W2050984893 created "2016-06-24" @default.
- W2050984893 creator A5022411304 @default.
- W2050984893 creator A5027551857 @default.
- W2050984893 creator A5032889136 @default.
- W2050984893 creator A5044192075 @default.
- W2050984893 creator A5083926802 @default.
- W2050984893 date "2000-09-01" @default.
- W2050984893 modified "2023-09-27" @default.
- W2050984893 title "Comparison of 0.5% intrathecal bupivacaine with 0.5% intrathecal ropivacaine in the treatment of refractory cancer and noncancer pain conditions: Results from a prospective, crossover, double-blind, randomized study" @default.
- W2050984893 cites W1967848210 @default.
- W2050984893 cites W1980830588 @default.
- W2050984893 cites W1982662391 @default.
- W2050984893 cites W2001440504 @default.
- W2050984893 cites W2004878854 @default.
- W2050984893 cites W2031828770 @default.
- W2050984893 cites W2041524447 @default.
- W2050984893 cites W2046868598 @default.
- W2050984893 cites W2046999173 @default.
- W2050984893 cites W2049285195 @default.
- W2050984893 cites W2063318435 @default.
- W2050984893 cites W2063842454 @default.
- W2050984893 cites W2080082123 @default.
- W2050984893 cites W2111041374 @default.
- W2050984893 cites W2131061433 @default.
- W2050984893 cites W2324903487 @default.
- W2050984893 cites W2892541563 @default.
- W2050984893 doi "https://doi.org/10.1053/rapm.2000.8574" @default.
- W2050984893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11009233" @default.
- W2050984893 hasPublicationYear "2000" @default.
- W2050984893 type Work @default.
- W2050984893 sameAs 2050984893 @default.
- W2050984893 citedByCount "14" @default.
- W2050984893 countsByYear W20509848932012 @default.
- W2050984893 countsByYear W20509848932013 @default.
- W2050984893 countsByYear W20509848932014 @default.
- W2050984893 countsByYear W20509848932015 @default.
- W2050984893 countsByYear W20509848932020 @default.
- W2050984893 crossrefType "journal-article" @default.
- W2050984893 hasAuthorship W2050984893A5022411304 @default.
- W2050984893 hasAuthorship W2050984893A5027551857 @default.
- W2050984893 hasAuthorship W2050984893A5032889136 @default.
- W2050984893 hasAuthorship W2050984893A5044192075 @default.
- W2050984893 hasAuthorship W2050984893A5083926802 @default.
- W2050984893 hasConcept C121332964 @default.
- W2050984893 hasConcept C141071460 @default.
- W2050984893 hasConcept C14184104 @default.
- W2050984893 hasConcept C142424586 @default.
- W2050984893 hasConcept C142724271 @default.
- W2050984893 hasConcept C168563851 @default.
- W2050984893 hasConcept C204787440 @default.
- W2050984893 hasConcept C27081682 @default.
- W2050984893 hasConcept C2778994108 @default.
- W2050984893 hasConcept C2779091618 @default.
- W2050984893 hasConcept C2780269707 @default.
- W2050984893 hasConcept C2781328992 @default.
- W2050984893 hasConcept C42219234 @default.
- W2050984893 hasConcept C71924100 @default.
- W2050984893 hasConcept C87355193 @default.
- W2050984893 hasConcept C87813604 @default.
- W2050984893 hasConceptScore W2050984893C121332964 @default.
- W2050984893 hasConceptScore W2050984893C141071460 @default.
- W2050984893 hasConceptScore W2050984893C14184104 @default.
- W2050984893 hasConceptScore W2050984893C142424586 @default.
- W2050984893 hasConceptScore W2050984893C142724271 @default.
- W2050984893 hasConceptScore W2050984893C168563851 @default.
- W2050984893 hasConceptScore W2050984893C204787440 @default.
- W2050984893 hasConceptScore W2050984893C27081682 @default.
- W2050984893 hasConceptScore W2050984893C2778994108 @default.
- W2050984893 hasConceptScore W2050984893C2779091618 @default.
- W2050984893 hasConceptScore W2050984893C2780269707 @default.
- W2050984893 hasConceptScore W2050984893C2781328992 @default.
- W2050984893 hasConceptScore W2050984893C42219234 @default.
- W2050984893 hasConceptScore W2050984893C71924100 @default.
- W2050984893 hasConceptScore W2050984893C87355193 @default.
- W2050984893 hasConceptScore W2050984893C87813604 @default.
- W2050984893 hasIssue "5" @default.
- W2050984893 hasLocation W20509848931 @default.
- W2050984893 hasLocation W20509848932 @default.
- W2050984893 hasOpenAccess W2050984893 @default.
- W2050984893 hasPrimaryLocation W20509848931 @default.
- W2050984893 hasRelatedWork W2008154057 @default.
- W2050984893 hasRelatedWork W2131061433 @default.
- W2050984893 hasRelatedWork W2160611829 @default.
- W2050984893 hasRelatedWork W2265098064 @default.
- W2050984893 hasRelatedWork W2377318027 @default.
- W2050984893 hasRelatedWork W2410458131 @default.
- W2050984893 hasRelatedWork W2528216394 @default.
- W2050984893 hasRelatedWork W4230519564 @default.
- W2050984893 hasRelatedWork W4247450932 @default.
- W2050984893 hasRelatedWork W118141465 @default.
- W2050984893 hasVolume "25" @default.
- W2050984893 isParatext "false" @default.
- W2050984893 isRetracted "false" @default.
- W2050984893 magId "2050984893" @default.
- W2050984893 workType "article" @default.